T
Thomas Lehmann
Researcher at University Hospital of Basel
Publications - 33
Citations - 1676
Thomas Lehmann is an academic researcher from University Hospital of Basel. The author has contributed to research in topics: Myeloproliferative neoplasm & Polycythemia vera. The author has an hindex of 11, co-authored 33 publications receiving 1476 citations. Previous affiliations of Thomas Lehmann include University of Basel.
Papers
More filters
Journal ArticleDOI
Temperature-Sensitive Indicators for Monitoring RBC Concentrates Out of Controlled Temperature Storage.
Joerg P. Sigle,Andreas Holbro,Thomas Lehmann,Laura Infanti,Sabine Gerull,Martin Stern,André Tichelli,Jakob Passweg,Andreas Buser +8 more
TL;DR: TIs identified a considerable number of RBC concentrates whose temperatures may not be adequately reflected by the 30-minute rule and stressed the necessity of validation prior to implementation.
Journal ArticleDOI
Sexuality Challenges, Intimacy, and MPN Symptom Burden: An Analysis By The MPN Quality Of Life International Study Group (MPN-QOL ISG)
Amylou C. Dueck,Robyn M. Emanuel,Keith Cannon,Jean-Jacques Kiladjian,S. Slot,Sonja Zweegman,Peter A. W. te Boekhorst,Suzan Commandeur,Harry C. Schouten,Federico Sackmann,Ana Kerguelen Fuentes,D. Hernández,Heike L. Pahl,Martin Griesshammer,Frank Stegelmann,Konstanze Döhner,Thomas Lehmann,Dana Ranta,Andreas Reiter,Françoise Boyer,Gabriel Etienne,Jean-Christophe Ianotto,Lydia Roy,Jean-Yves Cahn,Claire N. Harrison,Deepti Radia,Pablo J. Muxi,Norman Maldonado,Carlos Besses,Francisco Cervantes,Peter Johansson,Tiziano Barbui,Giovanni Barosi,Alessandro M. Vannucchi,Francesco Passamonti,Bjorn Andreasson,Maria Grazia Ferrari,Alessandro Rambaldi,Jan Samuelsson,Gunnar Birgegård,Zhijian Xiao,Zefeng Xu,Xiujuan Sun,Junqing Xu,Peihong Zhang,Robert Peter Gale,Ruben A. Mesa +46 more
TL;DR: This work sought to further analyze the relationships between issues of intimacy (sexual desire and function), their relationships to MPN disease features, individual MPN symptom prevalence and severity, language, and overall quality of life among an international cohort of patients with MPNs.
Journal ArticleDOI
Anti-Platelet Factor 4/Heparin Antibody Formation Occurs Endogenously and at Unexpected High Frequency in Polycythemia Vera.
Sara C. Meyer,Eva Steinmann,Thomas Lehmann,Patricia Muesser,Jakob Passweg,Radek C. Skoda,Dimitrios A. Tsakiris +6 more
TL;DR: Thrombotic risk increases in anti-PF4/heparin IgG-positive PV reflecting potential implications and calling for larger, confirmatory cohorts.
Journal ArticleDOI
The Myelofibrosis Symptom Burden (MF-SB): An International Phenotypic Cluster Analysis of 329 Patients
Holly L. Geyer,Amylou C. Dueck,Robyn M. Emanuel,Jean-Jacques Kiladjian,Stefanie Slot,Sonja Zweegman,Peter A. W. te Boekhorst,Suzan Commandeur,Harry C. Schouten,Federico Sackmann,Ana Kerguelen Fuentes,Dolores Hernández-Maraver,Heike L. Pahl,Martin Griesshammer,Frank Stegelmann,Konstanze Doehner,Françoise Boyer,Gabriel Etienne,Jean-Christophe Lanotto,Dana Ranta,Lydia Roy,Jean-Yves Cahn,Claire N. Harrison,Deepti Radia,Pablo J. Muxi,Norman Maldonado,Carlos Besses,Francisco Cervantes,Peter Johansson,Giovanni Barosi,Alessandro M. Vannucchi,Francesco Passamonti,Bjorn Andreasson,Maria L Ferarri,Alessandro Rambaldi,Jan Samuelsson,Gunnar Birgegård,Zhijian Xiao,Yue Zhang,Xiujuan Sun,Junqing Xu,Robert Peter Gale,Ayalew Tefferi,Peihong Zhang,Thomas Lehmann,Andreas Reiter,Karin Bonatz,Ruben A. Mesa +47 more
TL;DR: The Myelofibrosis Symptom Burden (MF-SB) : An International Phenotypic Cluster Analysis of 329 Patients shows clear trends in morbidity and mortality among patients diagnosed with MF.
Journal ArticleDOI
Symptom Burden Profile in Myelofibrosis Patients with Thrombocytopenia: Lessons and Unmet Needs
Holly L. Geyer,Robyn M. Scherber,Heidi E. Kosiorek,Amylou C. Dueck,Jean-Jacques Kiladjian,Zhijian Xiao,Stefanie Slot,Sonja Zweegman,Federico Sackmann,Ana Kerguelen Fuentes,Dolores Hernández-Maraver,Konstanze Döhner,Claire N. Harrison,Deepti Radia,Pablo J. Muxi,Carlos Besses,Francisco Cervantes,Peter L. Johansson,Bjorn Andreasson,Alessandro Rambaldi,Tiziano Barbui,Karin Bonatz,Andreas Reiter,Françoise Boyer,Gabriel Etienne,Jean-Christophe Ianotto,Dana Ranta,Lydia Roy,Jean-Yves Cahn,Norman Maldonado,Giovanni Barosi,Maria Grazia Ferrari,Robert Peter Gale,Gunnar Birgegård,Zefeng Xu,Yue Zhang,Xiujuan Sun,Junqing Xu,Peihong Zhang,Peter A. W. te Boekhorst,Suzan Commandeur,Harry C. Schouten,Heike L. Pahl,Martin Griesshammer,Frank Stegelmann,Thomas Lehmann,Alessandro M. Vannucchi,Francesco Passamonti,Jan Samuelsson,Ruben A. Mesa +49 more
TL;DR: The results of this study suggest that patients with thrombocytopenia will benefit from aggressive symptomatic control, potentially from targeted agents.